Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
基本信息
- 批准号:9244682
- 负责人:
- 金额:$ 46.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAddressAdverse effectsAnalgesicsAreaBasic ScienceBiologicalBiological FactorsCaringCharacteristicsClinicalClinical InvestigatorClinical ResearchDevelopmentDiagnosticDoseEconomic BurdenFailureFatigueFoundationsFunding OpportunitiesFutureGenomicsHealthHigh PrevalenceHumanImpaired wound healingIndividualInfectionInfection preventionInflammatoryInpatientsIntakeKnowledgeLeadLiquid substanceLogistic RegressionsMeasuresMissionModelingNociceptionNociceptorsNumeric Rating ScaleNursesOpioidOpioid AnalgesicsOutcomeOxygenPainPain ResearchPain intensityPain managementPatientsPharmaceutical PreparationsPneumoniaPreventionPreventiveProceduresPublic HealthReceiver Operating CharacteristicsRecommendationResearchResearch PersonnelRiskRoleSamplingScienceStatistical Data InterpretationSterile coveringsStressSymptomsTechnologyWorkassociated symptombasechronic woundcostcytokineeffective interventionexperiencehealingmicrobial communitymultidisciplinarynovelopen woundopioid usepain symptompredictive modelingpreventpublic health relevancesedativesymptom clustertoolwound
项目摘要
DESCRIPTION (provided by applicant): Wound care procedures, such as dressing changes, cause moderate to severe pain in 74% of patients, nearly half (36%) of whom experience severe pain (rated as 8 to 10 on a 10-point numeric rating scale). Severe pain causes substantial stress for both patient and nurse. Unfortunately, the high prevalence of severe pain during WCPs is under-recognized and under-studied. To date, mainstay recommendations to prevent pain during WCPs have focused on either administration of preventive and procedural analgesia or use of expensive, non-adherent dressings. However, it is unclear which patients to target for analgesia or expensive dressings, leading to their inappropriate over or under use. Analgesics are given to only 23% of patients undergoing WCPs and dressings that may decrease pain are given to even fewer. The ability to predict which patients are likely to have severe pain during WCPs is critically needed so that they can be targeted for preventive pain control strategies, including use of opioid analgesics and special dressings. Aim 1 of this study is to develop and evaluate a model to predict severe pain during WCPs. Although opioids are often given for highly painful conditions, they may not be an optimal or adequate strategy for controlling pain in open wounds because they impair wound healing and could lead to wound chronicity. The arsenal of alternatives to opioids is extremely limited because the biological mechanisms that contribute to nociceptive sensitivity and high pain during WCPs are unknown. Knowledge of these mechanisms would direct the development of new, effective interventions. Aim 2 is to identify these mechanisms. We have assembled an exceptional multi-disciplinary team of investigators to execute the aims of this proposal. These include investigators with expertise in: clinical research of chronic wounds (PI: Gardner), clinical (Investigator: Rakel) and
basic science (Consultant: Brennan) research of pain, genomic technologies to measure wound bioburden (Investigator: Grice), and statistical analyses, including receiver operating curves (Statistician: Hillis). To achieve the aims of the study, a comprehensive set of wound, patient, and biological factors will be measured concurrently with pain during a dressing change among a sample of 450 inpatients with open wounds. A predictive model will be developed and biological mechanisms will be examined using logistic regression. The model will be evaluated using receiver operator characteristic curves. The proposed study has the potential to make significant contributions because clinicians will be able to target those patients requiring preventive pain control, thereby eliminating the spiraling impact of painful procedures on nociceptor sensitization. In addition, the findings will provide foundational evidence for the development of needed, novel pain control strategies. The positive impact will be to optimize wound care, minimize adverse effects of pain and treatment, and reduce the costs associated with wound care.
描述(由申请人提供):伤口护理程序(如敷料更换)导致74%的患者出现中度至重度疼痛,其中近一半(36%)患者出现重度疼痛(在10分数字评定量表上评定为8至10分)。严重的疼痛会给病人和护士带来巨大的压力。不幸的是,WCP期间严重疼痛的高患病率未得到充分认识和研究。迄今为止,预防WCP期间疼痛的主要建议集中在预防性和程序性镇痛或使用昂贵的非粘性敷料。然而,目前尚不清楚哪些患者需要镇痛或昂贵的敷料,导致其不适当的过度或不足的使用。只有23%的接受WCP的患者使用止痛药,而使用可能减轻疼痛的敷料的患者更少。迫切需要预测哪些患者在WCP期间可能出现严重疼痛的能力,以便他们可以成为预防性疼痛控制策略的目标,包括使用阿片类镇痛药和特殊敷料。本研究的目的1是开发和评估一个模型,以预测严重疼痛在WCP。虽然阿片类药物通常用于高度疼痛的情况,但它们可能不是控制开放性伤口疼痛的最佳或适当策略,因为它们会损害伤口愈合并可能导致伤口慢性化。阿片类药物的替代品非常有限,因为在WCP期间导致伤害敏感性和高度疼痛的生物学机制尚不清楚。了解这些机制将指导制定新的有效干预措施。第二个目标是确定这些机制。我们已经组建了一个特殊的多学科调查小组,以执行这一建议的目标。这些研究人员包括具有以下专业知识的研究人员:慢性伤口的临床研究(PI:Gardner),临床(研究人员:Rakel)和
基础科学(顾问:Brennan)疼痛研究、测量伤口生物负载的基因组技术(研究者:Grice)和统计分析,包括受试者工作曲线(Staecian:Hillis)。为了实现研究目的,将在450例开放性伤口住院患者的样本中,同时测量伤口、患者和生物学因素的综合集合以及敷料更换期间的疼痛。将开发预测模型,并使用逻辑回归检查生物学机制。将使用受试者操作者特征曲线对模型进行评价。这项拟议的研究有可能做出重大贡献,因为临床医生将能够针对那些需要预防性疼痛控制的患者,从而消除疼痛手术对伤害性感受器致敏的螺旋式影响。此外,研究结果将为开发所需的新型疼痛控制策略提供基础证据。积极的影响将是优化伤口护理,最大限度地减少疼痛和治疗的不良影响,并降低与伤口护理相关的成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUE E GARDNER其他文献
SUE E GARDNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUE E GARDNER', 18)}}的其他基金
Exploratory Center of Excellence for Advancing Multimorbidity Science (CAMS)
促进多种疾病科学卓越探索中心 (CAMS)
- 批准号:
10121495 - 财政年份:2018
- 资助金额:
$ 46.79万 - 项目类别:
Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
- 批准号:
10416002 - 财政年份:2018
- 资助金额:
$ 46.79万 - 项目类别:
Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
- 批准号:
9762982 - 财政年份:2018
- 资助金额:
$ 46.79万 - 项目类别:
Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
- 批准号:
10416003 - 财政年份:2018
- 资助金额:
$ 46.79万 - 项目类别:
Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
- 批准号:
9070786 - 财政年份:2015
- 资助金额:
$ 46.79万 - 项目类别:
Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
- 批准号:
8896199 - 财政年份:2015
- 资助金额:
$ 46.79万 - 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
- 批准号:
8070041 - 财政年份:2007
- 资助金额:
$ 46.79万 - 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
- 批准号:
7626756 - 财政年份:2007
- 资助金额:
$ 46.79万 - 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
- 批准号:
7480996 - 财政年份:2007
- 资助金额:
$ 46.79万 - 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
- 批准号:
7320380 - 财政年份:2007
- 资助金额:
$ 46.79万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.79万 - 项目类别:
Research Grant














{{item.name}}会员




